Why National Pharmacare is bad for patients because it will reduce access to medicines for people with private drug plans without improving access for people with public drug plans.
Why National Pharmacare is not needed because all Canadians are already covered under existing private and public drug plans.
Value-based drug pricing helps us to understand the maximum amount of money we're willing to pay for treatments that could benefit patients and save lives.
Americans pay more for prescription drugs than people in most other Western countries.
Macroeconomic pressures have hit the R&D returns of life sciences firms.